Education
About Us
Working with TipRanks
Follow Us
Rossari Biotech Ltd (IN:ROSSARI)
:ROSSARI
Total Valuation
Rossari Biotech Ltd has a market cap or net worth of ₹35.18B. The enterprise value is ₹34.51B.
Market Cap₹35.18B
Enterprise Value₹34.51B
Share Statistics
Rossari Biotech Ltd has 55,366,966 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding55,366,966
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Rossari Biotech Ltd’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 26.04%.
Return on Equity (ROE)0.12
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)26.04%
Return on Capital Employed (ROCE)0.38
Revenue Per Employee46.23M
Profits Per Employee3.03M
Employee Count450
Asset Turnover1.10
Inventory Turnover4.04
Valuation Ratios
The current PE Ratio of Rossari Biotech Ltd is 26.0. Rossari Biotech Ltd’s PEG ratio is ―.
PE Ratio26.0
PS Ratio0.00
PB Ratio0.00
Price to Fair Value2.88
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio―
Income Statement
In the last 12 months, Rossari Biotech Ltd had revenue of 20.80B and earned 1.36B in profits. Earnings per share was 24.66.
Revenue20.80B
Gross Profit6.47B
Operating Income5.15B
Pretax Income1.85B
Net Income1.36B
EBITDA2.65B
Earnings Per Share (EPS)24.66
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Rossari Biotech Ltd pays an annual dividend of ₹0.5, resulting in a dividend yield of 0.08%
Dividend Per Share₹0.5
Dividend Yield0.08%
Payout Ratio4.10%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.91
52-Week Price Change-31.51%
50-Day Moving Average686.73
200-Day Moving Average712.91
Relative Strength Index (RSI)27.20
Average Volume (3m)6.91K
Important Dates
Rossari Biotech Ltd upcoming earnings date is Oct 27, 2025, TBA (Confirmed).
Last Earnings DateJul 19, 2025
Next Earnings DateOct 27, 2025
Ex-Dividend DateJun 20, 2025
Financial Position
Rossari Biotech Ltd as a current ratio of 1.94, with Debt / Equity ratio of 18.39%
Current Ratio1.94
Quick Ratio1.28
Debt to Market Cap0.06
Net Debt to EBITDA0.61
Interest Coverage Ratio28.90
Taxes
In the past 12 months, Rossari Biotech Ltd has paid 488.07M in taxes.
Income Tax488.07M
Effective Tax Rate0.26
Enterprise Valuation
Rossari Biotech Ltd EV to EBITDA ratio is 13.47, with an EV/FCF ratio of -169.51.
EV to Sales1.72
EV to EBITDA13.47
EV to Free Cash Flow-169.51
EV to Operating Cash Flow25.98
Balance Sheet
Rossari Biotech Ltd has ₹1.14B in cash and marketable securities with ₹2.18B in debt, giving a net cash position of ₹1.04B billion.
Cash & Marketable Securities₹1.14B
Total Debt₹2.18B
Net Cash₹1.04B
Net Cash Per Share₹18.70
Tangible Book Value Per Share₹169.88
Margins
Gross margin is 29.18%, with operating margin of 24.74%, and net profit margin of 6.56%.
Gross Margin29.18%
Operating Margin24.74%
Pretax Margin8.90%
Net Profit Margin6.56%
EBITDA Margin12.74%
EBIT Margin9.52%
Analyst Forecast
The average price target for Rossari Biotech Ltd is ₹764.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target₹764.00
Price Target Upside22.15% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast11.77%
EPS Growth Forecast-1.14%